Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
WhiteOak Capital Pharma and Healthcare Fund Direct Growth
NAV: 10 Jun '26
₹15.77
Min. for SIP
₹100
Fund size (AUM)
₹602.93 Cr
Expense ratio
0.83%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,877 | +5.85% | |
| 6 months | ₹30,000 | ₹32,500 | +8.33% | |
| 1 year | ₹60,000 | ₹65,830 | +9.72% |
Holdings (63)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.47% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 6.54% |
| Others CBLO | Unspecified | CBLO | 4.57% |
| Laurus Labs Ltd | Healthcare | Equity | 4.13% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.12% |
| Divi's Laboratories Ltd | Healthcare | Equity | 4.11% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.02% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.41% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 3.33% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 3.31% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.13% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 3.02% |
| Lupin Ltd | Healthcare | Equity | 2.97% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.64% |
| Ami Organics Ltd | Healthcare | Equity | 2.45% |
| CORONA Remedies Ltd. | Healthcare | Equity | 2.43% |
| Aurobindo Pharma Ltd Futures | Healthcare | Futures | 2.00% |
| Thyrocare Technologies Ltd | Healthcare | Equity | 1.98% |
| Dr. Reddy's Laboratories Ltd Futures | Healthcare | Futures | 1.97% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 1.93% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 1.83% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 1.79% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.78% |
| Aether Industries Ltd | Materials | Equity | 1.56% |
| Navin Fluorine International Ltd | Materials | Equity | 1.44% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 1.32% |
| Shaily Engineering Plastics Ltd | Materials | Equity | 1.31% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 1.29% |
| Strides Pharma Science Ltd | Healthcare | Equity | 1.27% |
| Vijaya Diagnostic Centre Ltd | Healthcare | Equity | 1.25% |
| Kovai Medical Center & Hospital Ltd | Healthcare | Equity | 1.25% |
| Pfizer Ltd | Healthcare | Equity | 1.24% |
| Poly Medicure Ltd | Healthcare | Equity | 1.23% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.14% |
| Ipca Laboratories Ltd | Healthcare | Equity | 1.02% |
| Aarti Pharmalabs Ltd. | Healthcare | Equity | 0.96% |
| Astrazeneca Pharma India Ltd | Healthcare | Equity | 0.95% |
| Senores Pharmaceuticals Ltd. | Healthcare | Equity | 0.85% |
| GOVERNMENT OF INDIA 37086 091 DAYS TBILL 22MY26 FV RS 100 | Financial | Treasury Bills | 0.83% |
| GOVERNMENT OF INDIA 36734 182 DAYS TBILL 28MY26 FV RS 100 | Financial | Treasury Bills | 0.83% |
| Divi's Laboratories Ltd Futures | Healthcare | Futures | 0.79% |
| Sudeep Pharma Ltd. | Healthcare | Equity | 0.74% |
| Supriya Lifescience Ltd | Healthcare | Equity | 0.73% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 0.73% |
| Innova Captab Ltd. | Healthcare | Equity | 0.69% |
| Mankind Pharma Ltd. | Healthcare | Futures | 0.67% |
| Zota Health Care Ltd | Healthcare | Equity | 0.63% |
| Procter & Gamble Health Ltd | Healthcare | Equity | 0.61% |
| Mankind Pharma Ltd. | Healthcare | Equity | 0.50% |
| MAX Healthcare Institute Ltd $$ | Healthcare | Futures | 0.37% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 0.33% |
| GOVERNMENT OF INDIA 36813 182 DAYS TBILL 11JU26 FV RS 100 | Financial | Treasury Bills | 0.33% |
| Apollo Hospitals Enterprise Ltd Futures | Healthcare | Futures | 0.30% |
| Tatva Chintan Pharma Chem Ltd | Materials | Equity | 0.24% |
| Orchid Pharma Ltd | Healthcare | Equity | 0.23% |
| GOVERNMENT OF INDIA 35967 364 DAYS TBILL 07MY26 FV RS 100 | Financial | Treasury Bills | 0.17% |
| GOVERNMENT OF INDIA 37077 091 DAYS TBILL 14MY26 FV RS 100 | Financial | Treasury Bills | 0.17% |
| GOVERNMENT OF INDIA 37175 091 DAYS TBILL 04JU26 FV RS 100 | Financial | Treasury Bills | 0.17% |
| GOVERNMENT OF INDIA 36789 182 DAYS TBILL 04JU26 FV RS 100 | Financial | Treasury Bills | 0.13% |
| Sun Pharmaceutical Inds. Ltd Futures | Healthcare | Futures | 0.09% |
| Fortis Healthcare (India) Ltd Futures | Healthcare | Futures | 0.07% |
| GOVERNMENT OF INDIA 36838 182 DAYS TBILL 18JU26 FV RS 100 | Financial | Treasury Bills | 0.03% |
| Net Payables | Unspecified | Net Payables | -6.38% |
See All
Minimum investments
Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +9.7% | +8.8% | +17.5% | +57.5% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 8 | 6 | 2 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
RMRamesh MantriJan 2024 - PresentView details
RM
Ramesh Mantri
Jan 2024 - Present
View details
DPDheeresh PathakJan 2024 - PresentView details
DP
Dheeresh Pathak
Jan 2024 - Present
View details
AAAshish AgrawalJan 2025 - PresentView details
AA
Ashish Agrawal
Jan 2025 - Present
View details
PBPiyush BaranwalJan 2024 - PresentView details
PB
Piyush Baranwal
Jan 2024 - Present
View details
TATrupti AgrawalMay 2025 - PresentView details
TA
Trupti Agrawal
May 2025 - Present
View details
About WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by WhiteOak Capital Mutual Fund. This scheme was made available to investors on 03 Jul 2018. Ramesh Mantri is the Current Fund Manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹36,503 Cr and the Latest NAV as of 10 Jun 2026 is ₹15.77.
The WhiteOak Capital Pharma and Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹500.
;
Investment Objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)--
Total AUM₹36,502.59 Cr
Date of Incorporation03 Jul 2018
Launch Date03 Jul 2018
AddressUnit No. B4, 6th Floor,Cnergy, Appasaheb Marathe Marg,Prabhadevi Mumbai 400025
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,